Kythera Biopharmaceuticals LLC

Kythera Biopharmaceuticals LLC

Kythera Biopharmaceuticals LLC

Overview
Date Founded

2004

Headquarters

27200 West Agoura Road,Suite 200,Calabasas, CA 91301-5127

Type of Company

Private

Employees (Worldwide)

51 - 100

Industries

Pharmaceuticals
Biotechnology
Hospitals & Patient Services

Company Description

Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA.

Contact Data
Trying to get in touch with decision makers at Kythera Biopharmaceuticals LLC? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Secretary & General Counsel

Vice President, Clinical Affairs

Senior Director, Intellectual Property

Vice President-Clinical Operations

Vice President, Medical Affairs

Vice President, Operations

Vice President, Quality

Senior Director

Senior Director

Associate Director

Board of Directors

President & Chief Executive Officer at Tobira Therapeutics, Inc.

Paths to Kythera Biopharmaceuticals LLC
Potential Connections via
Relationship Science
You
Kythera Biopharmaceuticals LLC
Recent Transactions
Details Hidden

Allergan Plc purchases Kythera Biopharmaceuticals LLC

Details Hidden

Kythera Biopharmaceuticals LLC issued Common Stock

Details Hidden

Kythera Biopharmaceuticals LLC issued Common Stock

Transaction Advisors
Underwriter

Advised onKythera Biopharmaceuticals LLC issued Common Stock

Investment Advisor

Advised onAllergan Plc purchases Kythera Biopharmaceuticals LLC

Escrow Agent

Advised onKythera Biopharmaceuticals LLC issued Common Stock

Legal Advisor

Advised onAllergan Plc purchases Kythera Biopharmaceuticals LLC

Legal Advisor

Advised onAllergan Plc purchases Kythera Biopharmaceuticals LLC

Legal Advisor

Advised onAllergan Plc purchases Kythera Biopharmaceuticals LLC

Advisors & Consultants
Legal Advisor

Partner at Davis Polk & Wardwell LLP

Advisor

President Elect/President at American Society for Laser Medicine & Surgery

Advisor

Former Vice President-Operations Planning at Amgen, Inc.

Key Stats and Financials As of
Market Capitalization
$1.96B
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants
Investors
Details Hidden

UCLA Venture Capital Fund invests in information technology and life sciences companies located in the US. It provides financing for start-up companies before they go public.

Details Hidden

WS Investment Co. is the investment fund of law firm Wilson Sonsini Goodrich & Rosati. The fund was formed in 1978 and has been managed throughout by Mario Rosati. All fundraising is internal, with mandatory participation by partners and is occasionally opened to associates. Among other investments, the fund was a pre-IPO investor in Google, Brocade (partner Larry Sonsini contributed the options he received from his post as a director), Juniper Networks and Avanex.

Details Hidden

BB&T Corporation (NYSE: BBT) is one of the largest financial services holding companies in the U.S. with $178.5 billion in assets and market capitalization of $21.6 billion, as of June 30, 2012. Based in Winston-Salem, N.C., the company operates approximately 1,800 financial centers in 12 states and Washington, D.C., and offers a full range of consumer and commercial banking, securities brokerage, asset management, mortgage and insurance products and services. A Fortune 500 company, BB&T is consistently recognized for outstanding client satisfaction by J.D. Power and Associates, the U.S. Small Business Administration, Greenwich Associates and others. BB&T's banking subsidiaries are organized as a group of community banks, each with a regional president, which allows decisions to be made locally, close to the client. This also makes BB&T's client service more responsive, reliable and empathetic. More information about BB&T and its full line of products and services is available at www.BBT.com. On April 2, 2012, BB&T completed its acquisition of the life and property and casualty insurance divisions of Roseland, N.J.-based Crump Group Inc. The acquisition adds approximately $300 million in annual revenues to BB&T's insurance businesses and significantly strengthens and diversifies BB&T's non-interest revenues. The acquisition creates the largest independent wholesale distributor of life insurance and the second largest provider of wholesale commercial insurance brokerage and specialty programs in the U.S. On July 31, 2012, BB&T completed its application to acquire BankAtlantic, the wholly-owned subsidiary of BankAtlantic Bancorp (NYSE: BBX), was approved by the Board of Governors of the Federal Reserve System and the Federal Deposit Insurance Corporation (FDIC). The North Carolina Office of the Commissioner of Banks also has approved the acquisition. BankAtlantic branches will be rebranded as BB&T in the fourth quarter.This acquisition strategy has contributed significantly to BB&T's success

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kythera Biopharmaceuticals LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kythera Biopharmaceuticals LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Kythera Biopharmaceuticals LLC.